Core Viewpoint - China Nuclear Technology (00611) announced the resignation of Mr. Li Hongwei as Chairman of the Board, Executive Director, and member of the Compensation Committee, effective January 27, 2026, due to work adjustments [1] Group 1: Leadership Changes - Mr. Li Hongwei will also cease to be the authorized representative of the company as per the Hong Kong Stock Exchange Listing Rules and the Companies Ordinance [1] - Following Mr. Li's resignation, Mr. Wang Haoying has been appointed as Chairman, Non-Executive Director, member of the Compensation Committee, Chairman of the Nomination Committee, and authorized representative, effective January 27, 2026 [1] - The composition of the Board Committees will change, with Mr. Li no longer serving as a member of the Compensation Committee and Chairman of the Nomination Committee; Mr. Wang will take over these roles [1]
中国核能科技：王浩莹获委任为董事会主席